Following a speeding ticket from the ASX IIQ released an announcement saying nothing to see here but wait until Monday for news.

"The new information to be delivered in the Poster presentation at the ASCO Annual Meeting 2025 on 1 June 2025 in Chicago is considered price sensitive. This poster presentation is currently confidential, tightly held and under embargo by ASCO and due for public release at 7:00 AM (CT) / 8:00 AM (ET) on the day of presentation (Sunday, 1 June 2025) and will be announced to the ASX before market opens on Monday, 2 June 2025."

"University of Queensland is currently drafting an Australian Provisional Patent Application (APPA) to protect its intellectual property rights covering the exosome ovarian cancer test. This draft patent application relies on the new data and results contained in the Poster which have been maintained as a trade secret and remains confidential. The draft APPA is not sufficiently final and is expected to be completed and lodged with the Australian Patent Office by 4:00 PM AEST on Friday, 30 May 2025 and relies on the Poster information remaining confidential until then."